Founded in 2007, Presicient is headquartered in London with offices in the US, India and China. It combines customer-driven insights on how a drug has performed in clinical trials with market intelligence regarding competition, regulatory environment, payor landscape and other external factors to enable the client to refine its product strategy. Prescient works with many of the leading multinational pharmaceutical companies, as well as a growing number of emerging biotech and specialty pharmaceutical organisations.
The addressable market for ‘Decision Support’ spend is valued at $1.4bn and is expected to grow at 10-12% p.a., driven by a growing volume of drugs under development and increasing market complexity in high growth areas such as oncology.
